2016-05-10 | Reiterated Rating | Canaccord Genuity | Buy | |
2016-04-30 | Reiterated Rating | Morgan Stanley | Hold | |
2016-04-07 | Initiated Coverage | Northland Securities | Outperform | |
2016-04-04 | Reiterated Rating | Canaccord Genuity | Buy | |
2016-02-20 | Reiterated Rating | Canaccord Genuity | Buy | |
2016-02-19 | Lower Price Target | Citigroup Inc. | $22.00 to $17.00 | |
2016-02-02 | Reiterated Rating | Canaccord Genuity | Buy | $28.00 |
2016-02-02 | Reiterated Rating | Cowen and Company | Buy | |
2015-12-21 | Reiterated Rating | Citigroup Inc. | Buy | $22.00 |
2015-12-17 | Downgrade | Credit Suisse | Neutral to Underperform | $20.00 to $12.00 |
2015-12-17 | Downgrade | Credit Suisse Group AG | Neutral to Underperform | $20.00 to $12.00 |
2015-11-01 | Reiterated Rating | Canaccord Genuity | Buy | $28.00 |
2015-10-05 | Reiterated Rating | Canaccord Genuity | Buy | |
2015-09-21 | Reiterated Rating | Canaccord Genuity | Buy | |
2015-09-15 | Reiterated Rating | Canaccord Genuity | Buy | $28.00 |
2015-08-19 | Initiated Coverage | Credit Suisse | Neutral | $20.00 |
2015-08-13 | Initiated Coverage | Morgan Stanley | Equal to Equal Weight | $17.00 |
2015-08-05 | Reiterated Rating | Canaccord Genuity | Buy | $28.00 |
2015-07-07 | Boost Price Target | Canaccord Genuity | Buy | $20.00 to $28.00 |
2015-05-10 | Reiterated Rating | SunTrust | Buy | $50.00 to $45.00 |
2015-05-10 | Reiterated Rating | SunTrust Banks Inc. | Buy | $50.00 to $45.00 |
2015-05-07 | Lower Price Target | Canaccord Genuity | Buy | $45.00 to $20.00 |
2015-04-13 | Initiated Coverage | SunTrust | Buy | $50.00 |
2015-02-17 | Set Price Target | Canaccord Genuity | Buy | $45.00 |
2014-06-17 | Boost Price Target | Canaccord Genuity | $36.00 to $45.00 | |
2014-04-15 | Initiated Coverage | Cowen and Company | Outperform | $45.00 |
2014-04-15 | Initiated Coverage | Canaccord Genuity | Buy | $36.00 |
2014-04-15 | Initiated Coverage | Citigroup Inc. | Buy | $60.00 |
2014-04-15 | Initiated Coverage | Morgan Stanley | Overweight | $79.00 |
2016-05-10 | Reiterated Rating | Canaccord Genuity | Buy | |
2016-04-30 | Reiterated Rating | Morgan Stanley | Hold | |
2016-04-07 | Initiated Coverage | Northland Securities | Outperform | |
2016-04-04 | Reiterated Rating | Canaccord Genuity | Buy | |
2016-02-20 | Reiterated Rating | Canaccord Genuity | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In VSAR 6 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
BlackRock Fund Advisors | 1.51M |
BlackRock Institutional Trust Company, N.A. | 0.55M |
BlackRock Investment Management, LLC | 0.13M |
RUSSELL FRANK CO/ | 76900 |
BLACKROCK ADVISORS LLC | 15820 |
BlackRock Group LTD | 8384 |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
New Leaf Ventures II, L.P. | 9.96% (2409374) | CMRX / DRTX / MEIP / VSAR / |
Advent Life Sciences LLP | 9.39% (2271558) | VSAR / |
AISLING CAPITAL III LP | 8.84% (2139568) | AGRX / DRTX / LOXO / TRXC / TTOO / VSAR / |
PERCEPTIVE ADVISORS LLC | 8.68% (2099563) | ACRX / AEGR / ALDX / BIOD / FOLD / LJPC / PLCC / RPRX / VSAR / ZGNX / |
Shepard Jay President and CEO | 2.49% (602298) | DRRX / MRNS / VSAR / |
Gut Robert Chief Medical Officer | 0.94% (227300) | VSAR / |
Westberg Paul Sr. VP, Business Development | 0.93% (225736) | VSAR / |
Woody Tracy M Chief Commercial Officer | 0.89% (215755) | VSAR / |
Ward Shane SVP, Legal and Compliance | 0.83% (201556) | VSAR / |
Brumm Joshua T Chief Financial Officer | 0.83% (201269) | VSAR / |
Stout Jay S SVP, Technical Operations | 0.77% (185646) | VSAR / |
Cleland Jeffrey L President and CEO | 0.59% (142396) | VSAR / |
Haas Kevin VP, Finance and PAO | 0.32% (78218) | VSAR / |
GREER R SCOTT | 0.18% (44380) | ASPX / INGN / NKTR / SIEN / STEM / VSAR / |
AKKARAJU SRINIVAS | 0.11% (26155) | ICPT / SGEN / VSAR / ZSPH / |
Hislop Colin Chief Medical Officer | 0.10% (24500) | ANTH / VSAR / |
Malik Shahzad | 0.10% (23880) | AGEN / CNAT / VSAR / |
SUN ANTHONY Y | 0.10% (23880) | VSAR / |
JENNINGS EDMON R | 0.09% (22380) | VSAR / |
Varian John | 0.09% (22280) | GALE / VSAR / XOMA / |
Index Ventures IV (Jersey) LP | 0.08% (19161) | VSAR / |
DOBMEIER ERIC | 0.08% (18160) | ATRA / SGEN / STML / VSAR / |